TY  - JOUR

T1  - Randomized trial of marker-directed versus standard schedule zoledronic acid for bone metastases from breast cancer.

JO  - Journal of Clinical Oncology

PY  - 2012/05/20

AU  - Coleman RE

AU  - Wright J

AU  - Houston S

AU  - Agrawal R

AU  - Purohit OP-K

AU  - Hayward L

AU  - Simmonds P

AU  - Waterhouse A

AU  - Marshall H

ED  - 

DO  - DOI: 10.1200/jco.2012.30.15_suppl.511

PB  - American Society of Clinical Oncology (ASCO)

VL  - 30

IS  - 15_suppl

SP  - 511

EP  - 511

Y2  - 2025/10/10

ER  -